No Data
No Data
Takeda Pharmaceutical, AC Immune Agree to Option and Licence Agreement, Including on Alzheimer's Treatment Candidate
Takeda Pharmaceutical (TAK) and AC Immune (ACIU) said Monday they have agreed to an exclusive, worldwide option and license agreement for AC Immune's immunotherapies, including its Alzheimer's disease treatment candidate.
Top Gap Ups and Downs on Monday: TM, BABA, STLA and More
Gaps can show signals that something important has happened to the fundamental or the psychology of traders that accompanies this market movement.
Sector Update: Health Care
Health care stocks were mixed late Monday afternoon with the NYSE Health Care Index up 0.1% and the Health Care Select Sector SPDR Fund (XLV) decreasing 0.2%. The iShares Biotechnology ETF (IBB) added
Why Is Small-Cap Alzheimer's-Focused AC Immune Stock Trading Higher On Monday?
Monday, Takeda Pharmaceutical Company Limited (NYSE:TAK) and AC Immune SA (NASDAQ:ACIU) announced an exclusive, worldwide option and license agreement for AC Immune's active immunotherapies targeting
AC Immune Enters Licensing Deal for Alzheimer's Disease Drug Candidate
AC Immune SA (IMR.F) said Monday it signed an exclusive option and license agreement with Japan's Takeda Pharmaceutical (TKD.F) for the former's ACI-24.060, a potential Alzheimer's disease drug treatm
AC Immune Rockets 47% on Alzheimer's Therapy Deal With Takeda
TrytosaveabitOP : AC Immune Eligible for $2.1B in Potential Milestones
74137893 : too fast to catch
TrytosaveabitOP 74137893: IMO it’s not done! NFA
Nuyoah : 又是这种突然暴涨,进入就被套